GI startup raises $30M

Iterative Scopes bagged $30 million in series A funding to develop its artificial intelligence-powered gastroenterology and drug development technology, according to BioWorld. The startup landed investments from Obvious Ventures, Eli Lilly, Johnson & Johnson Innovation-JJDC, and venture capital firms Breyer Capital and Seae Ventures.

Advertisement

Iterative Scopes’ algorithms currently offer two applications — one that assists clinicians in detecting polyps and another that uses colonoscopy images to help physicians determine a given patient’s clinical trial eligibility.
The Cambridge, Mass.-based startup, born out of the Massachusetts Institute of Technology in 2017, has raised $43.5 million over nine rounds of funding.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.